NCT00022555View on ClinicalTrials.gov

Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

July 31, 2003

Conditions
AIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell LymphomaAIDS-related Peripheral/Systemic LymphomaAIDS-related Small Noncleaved Cell Lymphoma
Interventions
DRUG

bryostatin 1

Given IV

DRUG

vincristine sulfate

Given IV

Trial Locations (1)

20850

AIDS - Associated Malignancies Clinical Trials Consortium, Rockville

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00022555 - Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma | Biotech Hunter | Biotech Hunter